C15H16O2, triclinic, P1̄ (no. 2), a = 5.6034(7) Å, b = 8.7105(11) Å, c = 12.5661(16) Å, α = 92.790(7)°, β = 100.516(7)°, γ = 106.105(6)°, V = 576.15(13) Å3, Z = 2, Rgt(F) = 0.0476, wRref(F2) = 0.1348, T = 296.15 K
C14H10O2, triclinic, P1 (no. 2), a = 7.498(3) Å, b = 7.973(3) Å, c = 9.660(4) Å, α = 67.211(13)°, β ...
C20H26O5, monoclinic, P21 (no. 4), a = 7.0011(5) Å, b = 12.3136(9) Å, c = 10.4847(8) Å, β = 105.734(...
C15H16N4O, monoclinic, P21/c (no. 14), a = 10.3021(8) Å, b = 15.7835(13) Å, c = 8.3052(7) Å, β = 90....
C15H16O, monoclinic, P21/c (no. 14), a = 5.4371(7) Å, b = 17.567(2) Å, c = 11.8840(18) Å, β = 101.04...
C20H30O4, orthorhombic, P21212 (no. 18), a = 12.6727(4) Å, b = 19.8422(7) Å, c = 7.5471(3) Å, V = 18...
C12H10O3, triclinic, P1̄ (no. 2), a = 7.2709(5) Å, b = 7.3228(5) Å, c = 9.4670(7) Å, α = 82.241(4)°,...
C17H14O5, monoclinic, P121/n1 (No. 14), a = 7.069(2) Å, b = 21.094(6) Å, c = 9.721(3) Å, β = 102.56(...
In the title compound, C20H16O3, the hydropyran ring adopts a distorted half-chair conformation with...
C16H11NO2, triclinic, P1̅, a = 7.3496(15) Å, b = 9.3709(17) Å, c = 9.4112(16) Å, α = 104.712(6)°, β ...
In the title compound, C20H16O3, the hydropyran ring adopts a distorted half-chair conformation with...
C30H52O3, orthorhombic, P212121 (no. 19), a = 6.71147(14) Å, b = 16.6565(4) Å, c = 25.0815(6) Å, V =...
C42H27MnN5O9·2H2O, triclinic, P1‾$P\overline{1}$ (no. 2), a = 12.4250(8) Å, b = 12.7259(8) Å, c = 14...
C19H20NO2, monoclinic, P21 (no. 4), a = 6.685(5) Å, b = 8.878(7) Å, c = 13.239(9) Å, β = 97.720(2)°,...
C24H18O3, monoclinic, P21/c (no. 14), a = 9.0474(7) Å, b = 19.9648(12) Å, c = 10.7153(3) Å, β = 104....
Tzvetkov NT, Neumann B, Stammler H-G, Mattay J. Crystal structure of (1aSR,3aRS,7aSR)-3a-but-2-ynyl-...
C14H10O2, triclinic, P1 (no. 2), a = 7.498(3) Å, b = 7.973(3) Å, c = 9.660(4) Å, α = 67.211(13)°, β ...
C20H26O5, monoclinic, P21 (no. 4), a = 7.0011(5) Å, b = 12.3136(9) Å, c = 10.4847(8) Å, β = 105.734(...
C15H16N4O, monoclinic, P21/c (no. 14), a = 10.3021(8) Å, b = 15.7835(13) Å, c = 8.3052(7) Å, β = 90....
C15H16O, monoclinic, P21/c (no. 14), a = 5.4371(7) Å, b = 17.567(2) Å, c = 11.8840(18) Å, β = 101.04...
C20H30O4, orthorhombic, P21212 (no. 18), a = 12.6727(4) Å, b = 19.8422(7) Å, c = 7.5471(3) Å, V = 18...
C12H10O3, triclinic, P1̄ (no. 2), a = 7.2709(5) Å, b = 7.3228(5) Å, c = 9.4670(7) Å, α = 82.241(4)°,...
C17H14O5, monoclinic, P121/n1 (No. 14), a = 7.069(2) Å, b = 21.094(6) Å, c = 9.721(3) Å, β = 102.56(...
In the title compound, C20H16O3, the hydropyran ring adopts a distorted half-chair conformation with...
C16H11NO2, triclinic, P1̅, a = 7.3496(15) Å, b = 9.3709(17) Å, c = 9.4112(16) Å, α = 104.712(6)°, β ...
In the title compound, C20H16O3, the hydropyran ring adopts a distorted half-chair conformation with...
C30H52O3, orthorhombic, P212121 (no. 19), a = 6.71147(14) Å, b = 16.6565(4) Å, c = 25.0815(6) Å, V =...
C42H27MnN5O9·2H2O, triclinic, P1‾$P\overline{1}$ (no. 2), a = 12.4250(8) Å, b = 12.7259(8) Å, c = 14...
C19H20NO2, monoclinic, P21 (no. 4), a = 6.685(5) Å, b = 8.878(7) Å, c = 13.239(9) Å, β = 97.720(2)°,...
C24H18O3, monoclinic, P21/c (no. 14), a = 9.0474(7) Å, b = 19.9648(12) Å, c = 10.7153(3) Å, β = 104....
Tzvetkov NT, Neumann B, Stammler H-G, Mattay J. Crystal structure of (1aSR,3aRS,7aSR)-3a-but-2-ynyl-...
C14H10O2, triclinic, P1 (no. 2), a = 7.498(3) Å, b = 7.973(3) Å, c = 9.660(4) Å, α = 67.211(13)°, β ...
C20H26O5, monoclinic, P21 (no. 4), a = 7.0011(5) Å, b = 12.3136(9) Å, c = 10.4847(8) Å, β = 105.734(...
C15H16N4O, monoclinic, P21/c (no. 14), a = 10.3021(8) Å, b = 15.7835(13) Å, c = 8.3052(7) Å, β = 90....